Balancing the right to know and the privacy of the patent system: a case study of oncology medicines in Thailand
by Inthira Yamabhai; Richard D. Smith
International Journal of Intellectual Property Management (IJIPM), Vol. 6, No. 4, 2013

Abstract: This study aims to illustrate the processes to determine medicine patent status in developing countries by using oncology medicine in Thailand as a case study. From 88 active ingredients, 31 active ingredients were found to have been filed for patent protection in Thailand, while seven medicines were unable to be verified as being patented. Patent identification is very complex and time-consuming, which leads to the inability to identify patented medicine. As such, developing countries may therefore find that they pay more than required for some medicines simply due to this lack of information. Government authorities in developing countries should therefore strengthen their systems for gathering, validating and disseminating patent information for pharmaceuticals to ensure that disclosure is on par with the developed world.

Online publication date: Tue, 12-Nov-2013

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email